Rockwell Medical (RMTI) Equity Ratio (2010 - 2026)

Rockwell Medical has reported Equity Ratio for 17 years, with the latest figure at 0.62 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio rose 6.89% year-over-year to 0.62; the trailing twelve-month figure through Mar 2026 stood at 0.62 (up 6.89% YoY), and the FY2025 full-year result was 0.65, up 17.58% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.62, down from 0.65 in the prior quarter.
• The five-year high for Equity Ratio was 0.65 in Q4 2025, with the low at 0.13 in Q1 2022.
• Historically, Equity Ratio has averaged 0.42 across 5 years, with a median of 0.41 in 2023.
• The largest YoY upside for Equity Ratio was 479.59% in 2022 against a maximum downside of 134.07% in 2022.
• Rockwell Medical's Equity Ratio stood at 0.3 in 2022, then soared by 34.91% to 0.41 in 2023, then surged by 34.87% to 0.55 in 2024, then advanced by 17.58% to 0.65 in 2025, then slipped by 3.51% to 0.62 in 2026.
• The last three Equity Ratio figures came in at 0.62 (Q1 2026), 0.65 (Q4 2025), and 0.64 (Q3 2025), per Business Quant data.